500
Participants
Start Date
November 15, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
July 31, 2026
Single nucleotide polymorphisms (SNP)
Utilizing single nucleotide polymorphisms (SNP) genotyping mosaic loss of y (mLOY) of individual patient will be assessed.
3'mRNA sequencing
3'mRNA sequencing analyzes gene expression profiles related to the immune response in different study cohorts, aiding in understanding the genetic underpinnings of inflammation and its association with mLOY.
Enzyme-linked immunosorbent assay (ELISA) and Legendplex Array
Used to measure cytokine levels in the serum of investigated patients, aiding in profiling inflammatory markers that are indicative of disease activity, response to treatment and consequence of mLOY..
Flow Cytometry
Employed to analyze immune cell phenotypes in investigated cohorts. This test helps identify various immune cell subsets and their activation states, which are critical for understanding disease mechanisms and its association with mLOY.
Laboratory assessment
Serum Chemistry
Assessment of Pulmonary Involvement
Results of routine clinical assessment of pulmonary involvement (such as lung ultrasound, computed tomography, chest x-ray, whole-body plethysmography) will be compared to mLOY, ELISA/ Legendplex/ flow cytometry/ transcriptome analysis results.
RECRUITING
Department of Rheumatology, Bonn
University of Bonn
OTHER